Skip to content

The new way prosecutors are using an old act

And how it's affecting drug CEOs

[jwp-video n="1"]

As the effects of the opioid crisis are felt across the country, federal prosecutors are taking action and prosecuting CEOs of pharmaceutical companies. The Controlled Substance Act is one of their most novel weapons. 

Watch as CQ Roll Call’s senior multimedia producer Jinitzail Hernández explains how.  

[jwp-video n=”1″]

Recent Stories

Rogers earmarks money for nonprofits he helped launch

Sporting it out  — Congressional Hits and Misses

Court extends block on ‘anti-weaponization’ fund

Photos of the week | June 5-11, 2026

Trump’s Wallet: From golf clubs to crypto, a decade of presidential finances

Senate panel sets markup on college sports bill